OlsonDR, SimonsenL, EdelsonPJ, MorseSS. Epidemiological evidence of an early wave of the 1918 influenza pandemic in New York City. Proc Natl Acad Sci U S A, 2005; 1102(31):11059-115063.
2.
MillerMA, ViboudC, BalinskaM, SimonsenL. The signature features of influenza pandemics—implications for policy. N Engl J Med, 2009; 360(25):2595-2598.
3.
LipsitchM, FinelliL, HeffernanRT, LeungGM, ReddSC. Improving the evidence base for decision making during a pandemic: the example of 2009 influenza A/H1N1. Biosecur Bioterror, 2011; 9(2):89-115.
4.
LipsitchM, RileyS, CauchemezS, GhaniAC, FergusonNM. Managing and reducing uncertainty in an emerging influenza pandemic. N Engl J Med, 2009; 361(2):112-115.
5.
SimonsenL, SpreeuwenbergP, LustigR, et al.Global mortality estimates for the 2009 influenza pandemic from the GLaMOR project: a modeling study. PLoS Med, 2013; 10(11):e1001558.
6.
WilsonN, BakerMG. The emerging influenza pandemic: estimating the case fatality ratio. Euro Surveill, 2009; 14(26):pii = 19255.
7.
GarskeT, LegrandJ, DonnellyCA, et al.Assessing the severity of the novel influenza A/H1N1 pandemic. BMJ, 2009; 339:b2840.
8.
PresanisAM, De AngelisD, et al.The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med, 2009; 6(12):e1000207.
9.
WhiteLF, WallingaJ, FinelliL, et al.Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA. Influenza Other Respir Viruses, 2009; 3(6):267-276.
10.
HatchettRJ, MecherCE, LipsitchM. Public health interventions and epidemic intensity during the 1918 influenza pandemic. Proc Natl Acad Sci U S A, 2007; 104(18):7582-7587.
11.
BootsmaMC, FergusonNM. The effect of public health measures on the 1918 influenza pandemic in U.S. cities. Proc Natl Acad Sci U S A, 2007; 104(18):7588-7593.
12.
US Department of Health and Human Services.. Interim Pre-pandemic Planning Guidance: Community Strategy for Pandemic Influenza Mitigation in the United States—Early, Targeted, Layered Use of Nonpharmaceutical Interventions. Washington, DC: HHS; February2007. https://www.cdc.gov/flu/pandemic-resources/pdf/community_mitigation-sm.pdf. Accessed June20, 2017.
HanleyJA, Lippman-HandA. If nothing goes wrong, is everything all right? Interpreting zero numerators. JAMA, 1983; 249(13):1743-1745.
15.
OrdT, HillerbrandR, SandbergA. Probing the improbable: methodological challenges for risks with low probabilities and high stakes. Journal of Risk Research, 2010; 13(2):191-205.
16.
KingG, ZengL. Logistic regression in rare events data. Political Analysis, 2001; 9(2):137-163.
17.
HanssonSO. Economic (ir)rationality in risk analysis. Economics and Philosophy, 2006; 22(2):231-241.
18.
SlovicP, FischhoffB, LichtensteinS. Behavioral decision theory perspectives on risk and safety. Acta Psychologica, 1984; 56(1):183-203.
19.
LipsitchM, EvansNG, Cotton-BarrattO. Underprotection of unpredictable statistical lives compared to predictable ones. Risk Anal, 2016; 37(5):893-904.
20.
AdaljaAA, TonerE, InglesbyTV. Clinical management of potential bioterrorism-related conditions. N Engl J Med, 2015; 372(10):954-962.
21.
LipsitchM, BarclayW, RamanR, et al.Viral factors in influenza pandemic risk assessment. Elife, 2016; 5:e18491.